Error loading player: No playable sources found

3220

Microbiome Therapeutics: Charting the Path to Clinical Success

Date
May 19, 2024

SOCIETY: AGA The session will highlight the current state of microbiome therapeutics, the challenges with developing and testing them in humans and the outlook for future of microbiome therapies beyond FMT.

Moderators

Speaker Image for Colleen Kelly
Brigham and Women's Hospital
Speaker Image for Jotham Suez
Johns Hopkins University

Related Products

Thumbnail for Pathogenic Mechanisms of Microbial Influences on Gut Inflammation and IBD
Pathogenic Mechanisms of Microbial Influences on Gut Inflammation and IBD
DIETARY FIBER-INDUCED ODORIBACTER METABOLITES PROMOTE MUCOSAL HEALING IN COLITIS
Thumbnail for Dietary and Microbial Derived Bioactive Compounds: Impact on Gastrointestinal Mucosal Health
Dietary and Microbial Derived Bioactive Compounds: Impact on Gastrointestinal Mucosal Health
SOCIETY: AGA Natural products obtained from diet or microbial derived metabolites are increasingly gaining attention for their potential therapeutic potential in gastro-intestinal disorders…
Thumbnail for Phage Wars and Fungal Foes: Exploring Tools and Mechanisms for Taming Inflammation
Phage Wars and Fungal Foes: Exploring Tools and Mechanisms for Taming Inflammation
SOCIETY: AGA This session will focus on the role of non-bacterial members of the microbiome including fungi and bacteriophages in regulating gut immune response and implications for therapeutic modulation…